GMPS

gene product
In the de novo synthesis of purine nucleotides, IMP is the branch point metabolite at which point the pathway diverges to the synthesis of either guanine or adenine nucleotides. In the guanine nucleotide pathway, there are 2 enzymes involved in converting IMP to GMP, namely IMP dehydrogenase (IMPD1), which catalyzes the oxidation of IMP to XMP, and GMP synthetase, which catalyzes the amination of XMP to GMP. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
44 antibodies from 13 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELIFIPIHFC
Aviva Systems Biology
3 antibodies
Abnova Corporation
5 antibodies
Novus Biologicals
8 antibodies
Acris Antibodies GmbH
7 antibodies
Bethyl Laboratories, Inc.
2 antibodies
Epitomics
3 antibodies
GeneTex
2 antibodies
Atlas Antibodies
1 antibody
Proteintech Group
1 antibody
Thermo Fisher Scientific Pierce
1 antibody
Creative Biomart
6 antibodies
LifeSpan BioSciences, Inc.
2 antibodies
Sigma-Aldrich
3 antibodies